NCT05212831View on ClinicalTrials.gov

Portable Oxygen Concentrator (POC) Versus Standard of Care in Long-COVID: Randomized Crossover Exploratory Pilot Study.

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 8, 2022

Primary Completion Date

March 2, 2023

Study Completion Date

March 2, 2023

Conditions
COVID-19
Interventions
DEVICE

Inogen One® G4

Inogen One® G4 will be used for a minimum of 3h per day at Setting 3 during the intervention period.

Trial Locations (2)

H1T1C8

Montreal Heart Institute, Montreal

H1T1N6

Centre ÉPIC de l'Institut de cardiologie de Montréal, Montreal

Sponsors

Lead Sponsor

Inogen Inc.
All Listed Sponsors
collaborator

The Montreal Health Innovations Coordinating Center (MHICC)

OTHER

lead

Inogen Inc.

INDUSTRY

NCT05212831 - Portable Oxygen Concentrator (POC) Versus Standard of Care in Long-COVID: Randomized Crossover Exploratory Pilot Study. | Biotech Hunter | Biotech Hunter